FGFR2 and neoplasm: In addition, nintedanib was recently shown to exert direct anti-tumor effect on tumor cells, but only those with oncogene addiction to growth factors receptors targeted by nintedanib, such as PDGFRα, FGFR2, FLT3, or RET (83).